Overview of the CLL2-BIG trial of ibrutinib and obinutuzumab VJHemOnc – Video Journal of Hematology & HemOnc 0:49 8 years ago 144 Далее Скачать
Overview of the CLL2-BIG trial VJHemOnc – Video Journal of Hematology & HemOnc 0:49 8 years ago 37 Далее Скачать
CLL2-GiVe trial: ibrutinib, venetoclax and obinutuzumab in patients with TP53-mutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:36 1 year ago 197 Далее Скачать
Obinutuzumab, ibrutinib, and venetoclax in high-risk CLL: the CLL2-GIVe and CLL13 trials VJHemOnc – Video Journal of Hematology & HemOnc 2:00 10 months ago 314 Далее Скачать
Dr. Kambhampati on Frontline Ibrutinib Plus Obinutuzumab in CLL OncLive 0:53 5 years ago 179 Далее Скачать
The combination of ibrutinib and obinutuzumab in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:18 7 years ago 283 Далее Скачать
Updates from the CLL14 and CLL2-GiVe trials on CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:03 8 years ago 154 Далее Скачать
Overview of CLL12 trial of ibrutinib aiming to delay chemoimmunotherapy VJHemOnc – Video Journal of Hematology & HemOnc 2:10 8 years ago 151 Далее Скачать
3-year follow-up of obinutuzumab, ibrutinib and venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 6:34 4 years ago 1 218 Далее Скачать
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia ecancer 4:27 6 years ago 165 Далее Скачать
Four-year follow-up from a Phase II study of obinutuzumab, ibrutinib, and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:43 2 years ago 318 Далее Скачать
GLOW: Assessing ibrutinib plus venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:54 2 years ago 366 Далее Скачать
Overview of RESONATE-2 clinical trial of ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:28 8 years ago 183 Далее Скачать
Results of a Phase Ib study of ibrutinib + obinutuzumab in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:58 2 years ago 134 Далее Скачать
Obinutuzumab, Ibrutinib, & Venetoclax in 17p / TP53 CLL - Dr. Stephan Stilgenbauer ASH 2022 CLL Society 11:39 1 year ago 189 Далее Скачать
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting VJHemOnc – Video Journal of Hematology & HemOnc 1:25 8 years ago 97 Далее Скачать
Dr. Rogers Discusses Obinutuzumab, Ibrutinib, and Venetoclax Combination in CLL OncLive 1:25 7 years ago 641 Далее Скачать
7-year update on a Phase II trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:44 6 months ago 294 Далее Скачать
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:11 8 years ago 270 Далее Скачать
